Cart
0
Get 20% Free Customization In This Report
Buy this report from - $4176

Small Animal Imaging (In-Vivo) Market by Technology (Micro-MRI, Optical Imaging, Nuclear Imaging) and Applications (Epigenetics, Biomarkers, Longitudinal Studies, Biodistribution Studies, Cancer Cell Tetection) - Global Opportunity Analysis and Industry Forecast, 2013 - 2020

LI_15474
Pages: 162
Feb 2015 | 3975 Views
face gplus_n
Author's : Deepa Tatkare
Tables: 59
Charts: 32
twit_n pr_n

Small Animal Imaging (In-Vivo) Market Overview: 

Small Animal Imaging (In-Vivo) Market is expected to garner $2.1 Billion by 2020, registering a CAGR of 9.1% during the forecast period 2014 to 2020. Imaging modalities emerged as a preferred option for the clinical industry, especially in preclinical studies.

Many of the nuclear imaging technologies have been translated into micro level tools that include micro MRI, micro CT and micro PET. Apart from these technologies, micro ultrasound imaging, micro-magnetic resonance imaging (MRI), optical Imaging such as bioluminescence and fluorescence imaging, and multimodal imaging technologies have gained traction in the market. Rising number of the pre-clinical research, increasing investments by the CROs in the research activities, growing applications of multi-functional pre-clinical imaging and technological advancements such as high resolution multimodality MRI are the few factors impacting the global market positively. However, the stringent regulatory impositions coupled with inadequate reimbursement scenario would restrain the market growth to a certain extent. Despite of the aforementioned market restraints, commercialization of cost-efficient devices would ease the negative influence of restraints and fuel the market growth, primarily across the developing regions.

Rising number of Pharmaceutical companies and clinical research organizations, increasing applications of in-vivo imaging in pre-clinical research, real time data storage and high-resolution modalities, are the key growth factors of the market. Inadequate infrastructure provisions for research facilities, advanced instruments and the lack of skilled research personnel in emerging economies along with the requirement of high-end devices are likely to be the major restraints of small animal imaging (in-vivo) market. Going forward, the global clinical research initiatives, along with the development in technologies associated with pre-clinical trials will provide the platform for growth.

North America, dominates the market amongst all geographies owing to adoption of advanced technologies, healthcare awareness and favorable reimbursement policies. Geographically, about ~35 of the small animal imaging (in-vivo) market share is held by the North America owing to the heavy investments and affordability of advanced small animal in-vivo imaging devices, such as micro- Photoacoustic tomography (Micro-PAT), in pre-clinical research. On the other hand, Asia-Pacific market would grow at the promising CAGR of 11.5% over the forecast period. Such high growth rate is majorly attributed towards untapped state of the market, hence would provide an opportunity for the small animal imaging devices manufacturers.

Global-Small-Animal-Imaging-Sidebar.jpg

Get more information on this report : Request Sample Pages

Small Animal Imaging (IN-VIVO) Market Key Benefits:

  • The report provides the quantitative analysis of the current market and estimations through 2013-2020 that assists in identifying the prevailing market opportunities to capitalize on
  • The report helps in understanding the strategies adopted by various companies for gaining market share in the small animal imaging (in-vivo) market
  • The report provides comprehensive analysis of factors that drive and restrict the growth of the small animal imaging (in-vivo) market
  • Market conditions of small animal imaging (in-vivo) market across all geographic regions are comprehensively analyzed. 
  • Competitive intelligence (of leading manufacturers) helps in understanding the competitive scenario across the geographies
  • SWOT analysis of the key market players is provided to illustrate the business strategies adopted by the companies

Small Animal Imaging (IN-VIVO) Market Segmentation:

The small animal imaging (in-vivo) market is segmented by the technology, applications and geography.

By Technology

  • Micro-Magnetic Resonance Imaging (Micro-MRI)
  • Optical Imaging (OI)
    • Bioluminescence Imaging
    • Cerenkov Luminescence Imaging
    • Fluorescence Imaging
  • Nuclear Imaging
    • Micro-Positron Emission Tomography (Micro-PET)
    • Micro-Single Photon Emission Computerized Tomography (Micro-SPECT)
  • Others 
    • Micro-Ultrasound Imaging
    • Micro-Computerized Tomography (Micro-CT)

By Applications

  • Monitoring Drug Treatment Response
  • Biodistribution Studies
  • Cancer Cell Detection
  • Biomarkers
  • Longitudinal Studies
  • Epigenetics

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA
 

Chapter: 1 INTRODUCTION

1.1 Key Benefits
1.2 Key Market Segments
1.3 Key Audiences
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 Market beyond what to expect by 2025 ($Million)

2.1.1 Moderate growth scenario
2.1.2 Rapid growth scenario
2.1.3 Diminishing growth scenario

Chapter: 3 MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Technological Advancements: Multimodality In Vivo Imaging

3.2.1 Multimodality Imaging
3.2.2 Cloud Computing and Real Time Data Storage

3.3 Emerging Economies as a beneficial criterion for investors
3.4 Key Findings

3.4.1 Top factors impacting for small animal imaging (In Vivo) market
3.4.2 Top investment pockets for small animal imaging (In Vivo) market
3.4.3 Top winning strategies for small animal imaging (In Vivo) market

3.5 Government Regulations and reimbursement

3.5.1 Regulations in United States
3.5.2 Regulations in Europe
3.5.3 Regulations in Asia Pacific
3.5.4 Reimbursement Scenario

3.6 Porter’s Five Force Analysis

3.6.1 Bargaining power of Suppliers (Lower)
3.6.2 Bargaining power of buyers (High)
3.6.3 Threats from substitute products (High)
3.6.4 Threat from new entrants (Low)
3.6.5 Moderate Industry rivalry

3.7 Value chain analysis
3.8 Patent Analysis

3.8.1 Patent Analysis by type of patents
3.8.2 Patent Analysis by Geography

3.9 Key market player positioning (2013)
3.10 Market dynamics

3.10.1 Growth Drivers

3.10.1.1 Increasing use of Multi functional pre clinical imaging
3.10.1.2 rising investments from clinical research organizations for pre clinical studies
3.10.1.3 rising number of pharmaceutical organizations and research institutions
3.10.1.4 Technological innovations such as combination of high resolution mri with other imaging  modalities  future growth driver

3.10.2 Restraints

3.10.2.1 Stringent regulatory requirements
3.10.2.2 Inadequate reimbursements   a barrier in In vivo imaging devices adoption
3.10.2.3 Accuracy and cost   a hindrance in worldwide adpotion of small animal imaging techniques

3.10.3 Opportunities

3.10.3.1 Development of new high resolution in vivo imaging techniques
3.10.3.2 Ultrasound contrast imaging techniques  An Opportunity to improve efficiency in the pre clinical drug discovery and development process

Chapter: 4 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET BY TECHNOLOGY

4.1 Micro Magnetic Resonance Imaging

4.1.1 Key market trends
4.1.2 Key growth factors and opportunities
4.1.3 Market size and forecast

4.2 Optical Imaging

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Bioluminescence Imaging
4.2.5 Cerenkov Luminescence Imaging
4.2.6 Fluorescence Imaging

4.3 Nuclear Imaging

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Micro  Positron Emission Tomography (Micro PET)
4.3.5 Micro Single Photon Emission Computerized Tomography (Micro SPECT)

4.4 Other Imaging Modalities

4.4.1 Micro Computerized Tomography Imaging

4.4.1.1 Key market trends
4.4.1.2 Key growth factors and opportunities

4.4.2 Micro Ultrasound Imaging

4.4.2.1 Key Market Trends
4.4.2.2 Key Growth Factors and Opportunities
4.4.2.3 Market size and forecast

Chapter: 5 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET BY APPLICATION

5.1 Monitoring Treatment Response

5.1.1 Market Size and forecast

5.2 Biodistribution, Determining Drug/Target Engagement

5.2.1 Market Size and forecast

5.3 Cancer cell detection

5.3.1 Market Size and forecast

5.4 Biomarkers

5.4.1 Market Size and forecast

5.5 Longitudinal studies

5.5.1 Market Size and forecast

5.6 Epigenetics

5.6.1 Market Size and forecast

Chapter: 6 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET BY GEOGRAPHY, 2013 2020, $MILLION

6.1 North America

6.1.1 Key Market Trends
6.1.2 Key growth factors and opportunities
6.1.3 Market size and forecast

6.2 Europe

6.2.1 Key market trends
6.2.2 Future growth factors and opportunities
6.2.3 Market size and forecast

6.3 Asia Pacific

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast

6.4 LAMEA

6.4.1 Key market trends
6.4.2 Future growth factors and opportunities
6.4.3 Market size and forecast

Chapter: 7 COMPANY PROFILES

7.1 Thermo Fisher Scientific

7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segment overview
7.1.4 Business performance
7.1.5 Strategic moves and developments
7.1.6 SWOT analysis

7.2 Siemens AG

7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segment overview
7.2.4 Siemens AG Business Performance
7.2.5 Strategic Moves And Developments
7.2.6 SWOT analysis of Siemens AG

7.3 Mediso Medical Imaging Systems

7.3.1 Company profile
7.3.2 Company snapshot
7.3.3 Operating business segment overview
7.3.4 Strategic moves and developments
7.3.5 SWOT analysis

7.4 Life Technologies Corporation

7.4.1 Company profile
7.4.2 Company snapshot
7.4.3 Operating business segment overview
7.4.4 Business performance
7.4.5 Strategic moves and developments
7.4.6 SWOT analysis of Life Technologies Corporation

7.5 Promega Corporation

7.5.1 Company profile
7.5.2 Company snapshot
7.5.3 Operating business segment overview
7.5.4 Business performance
7.5.5 Strategic Moves And Developments
7.5.6 SWOT analysis of Promega Corporation

7.6 Miltenyi Biotech GmbH

7.6.1 Company profile
7.6.2 Company snapshot
7.6.3 Operating business segment overview
7.6.4 Business Performance
7.6.5 Strategic moves and developments
7.6.6 SWOT analysis

7.7 Bruker Corporation

7.7.1 Company profile
7.7.2 Company snapshot
7.7.3 Operating business segment overview
7.7.4 Business Performance of Bruker Corporation
7.7.5 Strategic moves and developments
7.7.6 SWOT analysis of Bruker Corporation

7.8 FUJIFILM Holdings Corporation

7.8.1 Company Profile
7.8.2 Company snapshot
7.8.3 Business Performance of FujiFilm Holding Corporation
7.8.4 Business Performance of FujiFilm Holding Corporation:
7.8.5 Strategic moves and developments
7.8.6 SWOT Analysis of FujiFilm Holding Corporation

7.9 PerkinElmer, Inc.

7.9.1 Company Overview
7.9.2 Business Performance of PerkinElmer Inc.
7.9.3 Business Performance of PerkinEmer Inc.:
7.9.4 Strategic Moves and Development
7.9.5 SWOT analysis of PerkinElmer Inc.

7.10 Aspect Imaging Ltd.

7.10.1 Company Overview
7.10.2 Company snapshot
7.10.3 Business Performance of Aspect Imaging Ltd.
7.10.4 Strategic moves and developments
7.10.5 SWOT analysis

LIST OF TABLES

TABLE 1  MODERATE GROWTH RATE SCENARIO OF SMALL ANIMAL IMAGING (IN VIVO) MARKET, 2020–2025 ($MILLION)
TABLE 2  RAPID GROWTH RATE SCENARIO OF SMALL ANIMAL IMAGING (IN VIVO) MARKET, 2020–2025 ($MILLION)
TABLE 3  DIMINISHING GROWTH RATE SCENARIO OF SMALL ANIMAL IMAGING (IN VIVO) MARKET, 2020–2025 ($MILLION)
TABLE 4  PRODUCT LAUNCH AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN SMALL ANIMAL IMAGING (IN VIVO) MARKET, 2011 2014
TABLE 5  EXPANSION AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN SMALL ANIMAL IMAGING (IN VIVO) MARKET, 2012 2014
TABLE 6  ACQUISITION AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN SMALL ANIMAL IMAGING (IN VIVO) MARKET, 2012 2014
TABLE 7  MEDICAL DEVICES CATEGORIES ACCORDING TO EUROPEAN COMMISSION
TABLE 8  SUMMARY FOR GENERAL PROPERTIES OF IMAGING MODALITIES
TABLE 9  GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET BY TECHNOLOGY, 2013 2020 ($MILLION)
TABLE 10  GLOBAL SMALL ANIMAL MICRO MRI IMAGING MARKET BY GEOGRAPHY 2013   2020 ($MILLION)
TABLE 11  GLOBAL SMALL ANIMAL OPTICAL IMAGING MARKET BY GEOGRAPHY 2013   2020 ($MILLION)
TABLE 12  COMPARISON OF BIOLUMINESCENT IMAGING REPORTER PROTEINS
TABLE 13  TECHNOLOGICAL FEATURES OF COMMERCIALLY AVAILABLE MICRO PET SCANNERS
TABLE 14  GLOBAL SMALL ANIMAL NUCLEAR IMAGING MARKET BY GEOGRAPHY 2013   2020 ($MILLION)
TABLE 15  GLOBAL SMALL ANIMAL OTHER IMAGING MARKET BY GEOGRAPHY 2013   2020 ($MILLION)
TABLE 16  GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET BY APPLICATIONS, 2013 2020 ($MILLION)
TABLE 17  GLOBAL SMALL ANIMAL MONITORING TREATMENT APPLICATION MARKET BY GEOGRAPHY 2013   2020 ($MILLION)
TABLE 18  GLOBAL SMALL ANIMAL BIODISTRIBUTION APPLICATION MARKET BY GEOGRAPHY 2013   2020 ($MILLION)
TABLE 19  PERKINELMER OPTICAL IMAGING REAGENTS FOR PRE CLINICAL IMAGING OF CANCERS
TABLE 20  GLOBAL SMALL ANIMAL CANCER CELL DETECTION APPLICATION MARKET BY GEOGRAPHY 2013   2020 ($MILLION)
TABLE 21  GLOBAL SMALL ANIMAL BIOMARKERS APPLICATION MARKET BY GEOGRAPHY 2013   2020 ($MILLION)
TABLE 22  ADVANTAGES AND LIMITATIONS OF IMAGING MODALITIES USED IN LONGITUDINAL STUDIES
TABLE 23  GLOBAL SMALL ANIMAL LONGITUDINAL STUDIES APPLICATION MARKET BY GEOGRAPHY 2013   2020 ($MILLION)
TABLE 24  GLOBAL SMALL ANIMAL EPIGENETICS APPLICATION MARKET BY GEOGRAPHY 2013   2020 ($MILLION)
TABLE 25  GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET REVENUE BY GEOGRAPHY, 2013 – 2020 ($MILLION)
TABLE 26  NORTH AMERICA SMALL ANIMAL IMAGING (IN VIVO) MARKET BY TECHNOLOGY, 2013 – 2020 ($MILLION)
TABLE 27  EUROPE SMALL ANIMAL IMAGING (IN VIVO) MARKET BY TECHNOLOGY, 2013 – 2020 ($MILLION)
TABLE 28  ASIA PACIFIC SMALL ANIMAL IMAGING (IN VIVO) MARKET BY TECHNOLOGY, 2013 – 2020 ($MILLION)
TABLE 29  LAMEA SMALL ANIMAL IMAGING (IN VIVO) MARKET BY TECHNOLOGY, 2013 – 2020 ($MILLION)
TABLE 30  THERMO FISHER SCIENTIFIC COMPANY SNAPSHOT
TABLE 31  THERMO FISHER OPERATING SEGMENTS
TABLE 32  SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC
TABLE 33  SIEMENS AG. COMPANY SNAPSHOT
TABLE 34  SIEMENS AG OPERATING SEGMENTS
TABLE 35  SWOT ANALYSIS OF SIEMENS AG
TABLE 36  MEDISO MEDICAL IMAGING SYSTEMS COMPANY SNAPSHOT
TABLE 37  MEDISO MEDICAL IMAGING SYSTEMS OPERATING SEGMENTS
TABLE 38  SWOT ANALYSIS OF MEDISO MEDICAL IMAGING SYSTEMS.
TABLE 39  COMPANY SNAPSHOT LIFE TECHNOLOGIES CORPORATION COMPANY SNAPSHOT
TABLE 40  LIFE TECHNBOLOGIES CORPORATION OPERATING SEGMENTS
TABLE 41  SWOT ANALYSIS OF LIFE TECHNOLOGIES CORPORATION
TABLE 42  PROMEGA CORPORATION COMPANY SNAPSHOT
TABLE 43  PROMEGA CORPORATION OPERATING SEGMENTS
TABLE 44  SWOT ANALYSIS OF PROMEGA CORPORATION
TABLE 45  MILTENYI BIOTEC GMBH COMPANY SNAPSHOT
TABLE 46  MILTENYI BIOTEC GMBH OPERATING SEGMENTS
TABLE 47  SWOT ANALYSIS OF MILTENYI BIOTEC GMBH
TABLE 48  BRUKER CORPORATION COMPANY SNAPSHOT
TABLE 49  BRUKER CORPORATION OPERATING SEGMENTS
TABLE 50  SWOT ANALYSIS OF BRUKER CORPORATION
TABLE 51  FUJIFILM HOLDINGS CORPORATION COMPANY SNAPSHOT
TABLE 52  FUJIFILM HOLDING CORPORATION OPERATING SEGMENTS
TABLE 53  SWOT ANALYSIS OF FUJIFILM HOLDING CORPORATION
TABLE 54  PERKINELMER INC COMPANY SNAPSHOT
TABLE 55  PERKINELMER INC. OPERATING SEGMENTS
TABLE 56  SWOT ANALYSIS OF PERKINELMER INC
TABLE 57  ASPECT IMAGING LTD. SNAPSHOT
TABLE 58  ASPECT IMAGING LTD. OPERATING SEGMENTS
TABLE 59  SWOT ANALYSIS OF ASPECT IMAGING LTD.

LIST OF FIGURES

FIG. 1  IMPACT ANALYSIS OF MODERATE GROWTH SCENARIO (2020 2025)
FIG. 2  IMPACT ANALYSIS OF RAPID GROWTH SCENARIO (2020 2025)
FIG. 3  IMPACT ANALYSIS OF DIMINISHING GROWTH SCENARIO (2020 2025)
FIG. 4  MULTIMODALITY IMAGING INSTRUMENTS
FIG. 5  TOP IMPACTING FACTORS FOR SMALL ANIMAL IMAGING (IN VIVO) MARKET
FIG. 6  TOP INVESTMENT POCKETS OF GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET
FIG. 7  TOP WINNING STRATEGIES IN GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET 2011–2014
FIG. 8  TOP WINNING STRATEGIES IN GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET, 2011 2014
FIG. 9  PORTER’S FIVE FORCE MODEL OF BIO IMPLANTS MARKET
FIG. 10  VALUE CHAIN FOR SMALL ANIMAL IN VIVO IMAGING DEVICES
FIG. 11  PATENT ANALYSIS BY TYPE OF PATENTS (2012–2014)
FIG. 12  PATENT ANALYSIS BY GEOGRAPHY (2012–2014)
FIG. 13  MARKET PLAYER POSITIONING OF SMALL ANIMAL IMAGING (IN VIVO) MARKET, 2013 (MILLION)
FIG. 14  PHRMA MEMBER COMPANY R&D EXPENDITURES , 1995 2012 ($MILLION)
FIG. 15  GDP GROWTH (%) IN PHARMACEUTICAL AND RESEARCH ORGANIZATIONS, 2006 2050
FIG. 16  IN VIVO DETECTION OF RODENT BRAIN NEURO ARCHITECTURE USING MANGANESE ENHANCED MRI (MEMRI)
FIG. 17  HITACHI MICRO MRI IMAGING EQUIPMENT WITH MOSFET GATE
FIG. 18  BIODISTRIBUTION GRAPH  DEPICTING THE DRUG/TARGET ENGAGEMENT OVER THE SEQUENTIAL TIMEFRAME
FIG. 19  IMAGING IN THE CANCER MANAGEMENT
FIG. 20  THERMO FISHER SCIENTIFIC REVENUE BY BUSINESS UNITS, 2013 ($MILLION)
FIG. 21  THERMO FISHER SCIENTIFIC REVENUE BY GEOGRAPHY (2013)
FIG. 22  SIEMENS AG REVENUE BY GEOGRAPHY (2013)
FIG. 23  LIFE TECHNOLOGIES CORPORATION REVENUE BY BUSINESS SEGMENT (2012)
FIG. 24  LIFE TECHNOLOGIES CORPORATION REVENUE BY GEOGRAPHY (2012)
FIG. 25  PROMEGA CORPORATION REVENUE GENERATED (2011 2013)
FIG. 26  BRUKER CORPORATION REVENUE BY BUSINESS SEGMENT (2013)
FIG. 27  BRUKER CORPORATION REVENUE BY GEOGRAPHY (2013)
FIG. 28  BRUKER CORPORATION REVENUE GENERATED ($MILLION) (2011 2013)
FIG. 29  FUJIFILM HOLDINGS CORPORATION REVENUE BY BUSINESS SEGMENTS (IMAGING) (2013)
FIG. 30  FUJIFILM HOLDING CORPORATION REVENUE GENERATED 2011 2013 (IMAGING SEGMENT, $MILLION)
FIG. 31  PERKINELMER INC REVENUE BY BUSINESS SEGMENTS   2013 (HUMAN HEALTH)
FIG. 32  PERKINELMER REVENUE BY GEOGRAPHY (2012)

 

Conventional optical imaging is a rapid and relatively inexpensive imaging technology (as compared to other in-vivo imaging modalities) – still preferred by the end users (pharmaceutical and clinical research organizations). However, commercialization of the advanced in-vivo imaging systems (micro-MRI and nuclear imaging) with features such as real-time data storage and high-spatial resolution, would demonstrate lucrative opportunities within the global small animal imaging (in-vivo) market. Hence, manufacturers of small animal imaging (in-vivo) devices should target their entry into micro-MRI and nuclear imaging market segment. Bio-distribution and cancer cell detection applications market would grow at a significant rate owing to accuracy and precision in providing diagnostic information related to disease progression. Thus in coming years, in-vivo imaging modalities would replace other diagnostic methods in cancer research such as polymerase chain reaction (PCR), colonoscopy and endoscopy.

Geographically, the North American market is the most attractive among rest of the regional markets owing to high adoption rate of advanced and real time data storage imaging modalities. Such adoption is backed by high purchasing power; and favourable regulatory scenarios. Furthermore, Asia Pacific market which is low cost clinical destinations, is posed to grow at a highest rate chiefly due to increasing clinical research for cancer cell detection. 

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Request sample

OR

Purchase Full Report of
Small Animal Imaging (In-Vivo) Market- Global Opportunity Analysis and Industry Forecast, 2013 - 2020

  • Online Only
  • $4176
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540
  • Restricted to one authorized users
  • One print only
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $9280
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo